Encyclopedia of Clinical Neuropsychology

2018 Edition
| Editors: Jeffrey S. Kreutzer, John DeLuca, Bruce Caplan


  • Beth A. JerskeyEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-57111-9_1398


Diabetic retinopathy


Retinopathy is a general term that refers to noninflammatory damage to the retina of the eye. Usually the result of a systemic disease that induces changes in blood supply to the retina, a few of the more common causes of retinopathy are diabetes, hypertension, and premature birth. However, there are many possible etiologies that have direct and indirect effects on the retina (e.g., overexposure to sunlight, occlusion, or macroaneurysm of ocular blood supply). Many types of retinopathies are progressive in nature and often lead to partial vision loss or blindness. Treatment is dependent on the underlying cause and the extent of retinal damage.

Current Knowledge

Although each disease process responsible for the manifestations of retinopathy has specific effects on the retina, the majority of retinopathies follow a similar pattern. Blood flow to the retina is disrupted leading to hemorrhage with potential subsequent hypoxia of the surrounding...

This is a preview of subscription content, log in to check access.

References and Readings

  1. Abrishami, M., Heravian, J., Derakhshan, A., Mousavi, M., Banaee, T., Daneshvar, R., et al. (2007). Abnormal Cambridge low-contrast grating sensitivity results associated with diabetic retinopathy as a potential screening tool. Eastern Mediterranean Health Journal, 13(4), 810–818.PubMedGoogle Scholar
  2. Cugati, S., Cikamatana, L., Wang, J. J., Kifley, A., Liew, G., & Mitchell, P. (2006). Five-year incidence and progression of vascular retinopathy in persons without diabetes: The blue mountains eye study. Eye, 20, 1239–1245.PubMedCrossRefPubMedCentralGoogle Scholar
  3. El-Remessy, A. B., Al-Shabrawey, M., Khalifa, Y., Tsai, N. T., Caldwell, R. B., & Liou, G. I. (2006). Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. American Journal of Pathology, 168, 235–244.PubMedCrossRefPubMedCentralGoogle Scholar
  4. Harney, F. (2006). Diabetic retinopathy. Medicine, 34(3), 95–98.CrossRefGoogle Scholar
  5. Kanski, J. J. (1994). Diabetic retinopathy. In Clinical ophthalmology (pp. 344–357). London: Butterworth.Google Scholar
  6. Klein, R., Klein, B. E., & Moss, S. E. (1997). The relation of systemic hypertension to changes in the retinal vasculature: The beaver dam eye study. Transactions of the American Ophthalmological Society, 95, 329–348.PubMedPubMedCentralGoogle Scholar
  7. Lobo, C. L., Bernardes, R. C., & Cunha-Vaz, J. G. (2000). Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Archives in Ophthalmology, 118, 1364–1369.CrossRefGoogle Scholar
  8. Stavrou, E. P., & Wood, J. M. (2003). Letter contrast sensitivity changes in early diabetic retinopathy. Clinical and Experimental Optometry, 86(3), 152–156.PubMedCrossRefGoogle Scholar
  9. van Leiden, H. A., Dekker, J. M., Moll, A. C., Nijpels, G., Heine, R. J., Bouter, L. M., et al. (2003). Risk factors for incident retinopathy in a diabetic and nondiabetic population: The Hoorn study. Archives of Ophthalmology, 121, 245–251.PubMedCrossRefGoogle Scholar
  10. Wipf, J. E., & Paauw, D. S. (2000). Ophthalmologic emergencies in the patient with diabetes. Endocrinology and Metabolism Clinics of North America, 29(4), 813–829.PubMedCrossRefGoogle Scholar
  11. Wong, R., Khan, J., Adewoyin, T., Sivaprasad, S., Arden, G. B., & Chong, V. (2008). The ChromaTest, a digital color contrast sensitivity analyzer, for diabetic maculopathy: A pilot study. BMC Ophthalmology, 17, 8–15.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Psychiatry and Human BehaviorAlpert Medical School of Brown University Butler HospitalProvidenceUSA